L. O'Hanlon | Semantic Scholar

Natural born killers: NK cells drafted into the cancer fight.

L. O'Hanlon
Medicine
Journal of the National Cancer Institute
5 May 2004

High meat consumption linked to gastric-cancer risk.

L. O'Hanlon
Medicine
The Lancet. Oncology
1 April 2006

Taking down tumors: vascular disrupting agents entering clinical trials.

L. O'Hanlon
Biology
Journal of the National Cancer Institute
7 September 2005

Rather than obliterate cancer cells and surrounding nonmalignant cells, VDAs would go straight to the endothelia of tumor blood vessels and destroy them, while leaving surrounding tissue untouched.

View on PubMed

Scientists are searching the seas for cancer drugs.

L. O'Hanlon
Biology, Medicine
Journal of the National Cancer Institute
17 May 2006

View on PubMed

Studies seek molecular clues on alcohol's role in cancer.

L. O'Hanlon
Medicine
Journal of the National Cancer Institute
2 November 2005

A recent study found that acetaldehyde can interact with polyamines — small molecules essential for cell division — to trigger a series of events that eventually lead to damaged DNA, which has previously been observed in cells treated with acetaldehyde.

View on PubMed

Invasive melanoma on the rise in Californian Hispanics.

L. O'Hanlon
Medicine
The Lancet. Oncology
1 March 2006

View on PubMed

Ovarian transplants restore fertility in cancer patients

L. O'Hanlon
Medicine, Biology
Nature Medicine
22 July 2004

Conventional cancer treatments such as chemotherapy and radiation often carry one lasting side effect: sterility. But recent advances offer some hope in preserving the fertility of young female…

View on Nature

How next-generation sequencing could change cancer care.

L. O'Hanlon
Medicine
Journal of the National Cancer Institute
19 June 2013

Much more data is needed before one can change regimens from anthracycline to taxanes and that evaluation of ejection fraction should be done before starting therapy, according to the authors, who noted that the first two studies were retrospective, with limitations.

View on PubMed

Deep-sea creatures yield treasure trove of cancer drugs

L. O'Hanlon
Biology
Nature Medicine
1 July 2005

An expedition to the Republic of Palau in Micronesia has led to the discovery that microbes inside a bright green creature that lives in tropical oceans produce peptides that can kill cancer cells, proof that marine organisms can be harnessed for drug discovery and the turning point in commercializing the potential of marine natural products.

View on Nature

Studying the connection between exercise and cancer risk reduction.

L. O'Hanlon
Education
Journal of the National Cancer Institute
5 June 2013

When Leslie Bernstein, Ph.D., submitted a paper that found when younger women exer‐ cised for 4 hours per week they lowered their breast cancer risk by 50%, the editor of the journal refused to…

View on PubMed